TrialStem cells translational medicine2018

Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction.

Cesar Ariel Keller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.